secwatch / observer
8-K filed May 6, 2026, 7:59 PM ET ticker CORZ CIK 0001839341
debt confidence high sentiment neutral materiality 0.85

Core Scientific, Inc./tx (CORZ): debt financing — Core Scientific subsidiary prices $3.3B of 7.750% senior secured notes due 2031

Core Scientific, Inc./tx

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

Core Scientific, Inc./tx incurred senior notes of $3.3 billion with Wilmington Savings Fund Society, FSB at 7.750% maturing May 15, 2031.

Instrument
senior notes
Principal
$3.3 billion
Counterparty
Wilmington Savings Fund Society, FSB
Rate
7.750%
Maturity
May 15, 2031
Event
incurrence
Exact text from the filing
On May 6, 2026, Core Scientific Finance I LLC (the “Issuer”), a wholly-owned indirect subsidiary of Core Scientific, Inc. (“Core Scientific”), completed its previously announced private offering (the “Offering”) of $3.3 billion aggregate principal amount of its 7.750% Senior Secured Notes due 2031 (the “Notes”).
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

Core Scientific, Inc./tx entered into Indenture with Wilmington Savings Fund Society, FSB valued at $3.3 billion (effective 2026-05-06).

Action
entry
Agreement
notes offering
Counterparty
Wilmington Savings Fund Society, FSB
Value
$3.3 billion
Effective
2026-05-06
Exact text from the filing
the Notes were issued pursuant to, and are governed by, an indenture (the “Indenture”), dated as of May 6, 2026, between the Issuer, Holdco (as defined below), the Subsidiary Guarantors and Wilmington Savings Fund Society, FSB, as trustee (the “Trustee”) and collateral agent (the “Collateral Agent”)
View on SEC.gov

101 debt financings filed in the last 30 days. Browse all debt financings →

Core Scientific, Inc./tx filing history →

Source: SEC EDGAR
accession 0001193125-26-208905
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.